Track: Genetics of Diabetes

Diabetes 2026

Session Overview

This session provides a comprehensive overview of genetic influences in diabetes, emphasizing the role of heredity and molecular biology in disease development. It discusses how genetic research contributes to risk prediction, early diagnosis, and personalized treatment approaches.


Key Topics

Genetic Predisposition to Type 1 and Type 2 Diabetes: Genetic factors influence susceptibility to both Type 1 and Type 2 diabetes, including immune-related genes in Type 1 and metabolic pathway genes in Type 2.


Monogenic Diabetes and MODY: Monogenic diabetes, including Maturity-Onset Diabetes of the Young (MODY), results from single-gene mutations affecting insulin production or action and often requires specific treatment approaches.


Genome-wide Association Studies (GWAS): GWAS identify genetic variants linked to diabetes risk and help uncover biological pathways involved in disease development.


Genetic Testing and Counseling: Genetic testing can help confirm diagnosis, guide treatment decisions, and provide counseling for affected families, particularly in monogenic diabetes.


Epigenetics and Gene-Environment Interactions: Epigenetic changes and interactions between genes and lifestyle factors contribute to diabetes risk and may explain differences in disease progression among individuals.


Learning Objectives

Participants will understand the genetic and molecular basis of diabetes and how heredity contributes to disease susceptibility. The session aims to enhance knowledge of genetic testing, counseling, and personalized medicine approaches. Attendees will learn how genetic discoveries can improve early diagnosis and guide targeted treatment strategies. The session also emphasizes the role of gene-environment interactions and epigenetic mechanisms in diabetes development.